TPH2 explained

Tryptophan hydroxylase 2 (TPH2) is an isozyme of tryptophan hydroxylase found in vertebrates. In humans, TPH2 is primarily expressed in the serotonergic neurons of the brain, with the highest expression in the raphe nucleus of the midbrain. Until the discovery of TPH2 in 2003,[1] serotonin levels in the central nervous system were believed to be regulated by serotonin synthesis in peripheral tissues, in which tryptophan hydroxylase is the dominant form.[2]

Function

Tryptophan hydroxylase (TPH; EC 1.14.16.4) is the rate-limiting enzyme in the synthesis of serotonin (5-hydroxytryptamine, or 5HT). 5HT is causally involved in numerous central nervous activities, and it has several functions in peripheral tissues, including the maintenance of vascular tone and gut motility.[supplied by OMIM][3]

Disabling this enzyme with drugs (especially p-chlorophenylalanine aka PCPA and Fenclonine) has allowed researchers to investigate the effects of very low serotonin levels on humans and others animals, and by extension, gain insights into the functions of serotonin systems more broadly (such as hypersexuality in rodents as well as increased aggression and hypersexuality cats following PCPA administration[4]). In rat brain, administration of a single PCPA injection resulted in the lowest level of serotonin production occurring on day 2 and returning to control values on day 7.[5] Drugs such as MDMA[6] and methamphetamine[7] have been shown to lower levels of this enzyme which may result in periods of low serotonin levels following drug use. In a study investigating the effects of Fenclonine on humans, the greatly lowered serotonin levels were associated with "fatigue, dizziness, nausea, uneasiness [anxiety], fullness in the head [a feeling of pressure in the head] paresthesias [a pricking, pins-and-needles, burning, and/or aching sensation--typically the limbs], headache, and constipation".[8]

See also

Further reading

Notes and References

  1. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M . Synthesis of serotonin by a second tryptophan hydroxylase isoform . Science . 299 . 5603 . 76 . January 2003 . 12511643 . 10.1126/science.1078197 . 7095712 .
  2. Zill P, Büttner A, Eisenmenger W, Möller HJ, Ackenheil M, Bondy B . Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study . Journal of Psychiatric Research . 41 . 1–2 . 168–173 . 2005 . 16023677 . 10.1016/j.jpsychires.2005.05.004 .
  3. Web site: Entrez Gene: TPH2 tryptophan hydroxylase 2.
  4. Ferguson J, Henriksen S, Cohen H, Mitchell G, Barchas J, Dement W . "Hypersexuality" and behavioral changes in cats caused by administration of p-chlorophenylalanine . Science . 168 . 3930 . 499–501 . April 1970 . 5461688 . 10.1126/science.168.3930.499 . 1970Sci...168..499F . 16691506 .
  5. Richard F, Sanne JL, Bourde O, Weissman D, Ehret M, Cash C, Maître M, Pujol JF . 6 . Variation of tryptophan-5-hydroxylase concentration in the rat raphe dorsalis nucleus after p-chlorophenylalanine administration. I. A model to study the turnover of the enzymatic protein . Brain Research . 536 . 1–2 . 41–45 . December 1990 . 2150773 . 10.1016/0006-8993(90)90006-w . 12214077 .
  6. Bonkale WL, Austin MC . 3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus . Neuroscience . 155 . 1 . 270–276 . July 2008 . 18515011 . 2505057 . 10.1016/j.neuroscience.2008.03.086 .
  7. Hotchkiss AJ, Gibb JW . Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain . The Journal of Pharmacology and Experimental Therapeutics . 214 . 2 . 257–262 . August 1980 . 6104722 .
  8. Cremata VY, Koe BK . Clinical and biochemical effects of fenclonine: a serotonin depletor . Diseases of the Nervous System . 29 . 5 . Suppl:147–Suppl:152 . May 1968 . 5673619 . 2 July 2022 .